Oncology Data Advisor

By i3 Health

What's Oncology Data Advisor about?

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Download our free app to listen on your phone

Oncology Data Advisor episodes:

04.24.2024
Celebrating Head and Neck Cancer Awareness Month
In celebration of Head and Neck Cancer Awareness Month this April, Oncology Data Advisor Fellows Forum and Editorial Board Members Samuel Kareff, MD, MPH; Matthew Hadfield, DO; and Nagashree Seetharamu, MD, sat down to discuss the epidemiology of head and...
04.19.2024
Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability
This April, Oncology Data Advisor is raising awareness for Esophageal Cancer Awareness Month. In this interview, Oncology Data Advisor Editorial Board and Fellows Forum members Dr. Joseph Kalis, Dr. Matthew Hadfield, and Dr. Samuel Kareff discuss rising trends, treatment advances,...
04.17.2024
Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on LINKER-MM1 From AACR 2024
In this interview from the American Association for Cancer Research (AACR) 2024 Annual Meeting, Dr. Alankrita Taneja, third-year Hematology/Oncology Fellow at Roswell Park Cancer Institute and Oncology Data Fellows Forum Member, speaks with Dr. Sundar Jagannath, Professor of Medicine (Hematology...
$Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on LINKER-MM1 From AACR 2024$
04.15.2024
Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass
In this interview, Jason Mouabbi, MD, an Oncology Data Advisor Editorial Board Member and Assistant Professor in the Department of Breast Oncology at the University of Texas MD Anderson Cancer Center, sat down with Valerie Brutus, MD, FACS, a Breast...
04.12.2024
AYA Cancer Awareness Week 2024
Adolescent and Young Adult (AYA) Cancer Awareness Week, April 1 to 5, 2024, is a time to shine a spotlight on adolescent and young adult cancer patients and survivors. To commemorate the week, Lauren Ghazal, Megan-Claire Chase, and Allison Rosen,...
04.12.2024
Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD
Dr. Christopher Lieu, Associate Director of Clinical Research at the University of Colorado Cancer Center and Vice Chair of the National Comprehensive Cancer Network (NCCN), is currently serving as chair of i3 Health's online activity, live webinar, and meeting series,...
04.11.2024
National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO
In this edition of the Oncology Data Fellows Forum in celebration of National Doctor's Day, Samuel Kareff, MD, MPH, and Matthew Hadfield, DO, discuss the highs and lows of working in this field and why it is important to take...
04.11.2024
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes
In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors...
04.10.2024
Fighting Hereditary Colorectal Cancer With Genetic Counseling: Catherine Skefos and Julie Moskowitz
In this edition of "Bridging the Gap in Cancer Care Through Genetic Counseling," Editorial Member Catherine Skefos speaks with her colleague Julie Moskowitz, MS, Genetic Counselor in the Gastrointestinal (GI) Center at MD Anderson Cancer Center, about hereditary aspects of...
04.09.2024
International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship
In this panel discussion in honor of International Women's Day on March 8, Dr. Richa Thakur, Dr. Nida Khan, Dr. Lauren Ghazal, and Dr. Gurbakhash Kaur discuss their perspectives as women in the fields of medicine and nursing, including their...
04.08.2024
Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD
Dr. Spero Cataland, Professor of Internal Medicine and the Benign Hematology Section Head at The Ohio State University, Wexner Medical Center, is currently serving as chair of i3 Health's free CME/NCPD activity and Hematology Fellows Lecture Series, Current Standards and...
04.08.2024
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling
In this interview for Kidney Cancer Awareness Month, Hiam Abdel-Salam, MS, CGC, speaks with Donika Saporito, MS, a Certified Genetic Counselor in the Genitourinary Center at MD Anderson Cancer Center, who provides an overview of genetic testing for hereditary kidney...
04.05.2024
Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD
Last year, Brian Rubin, MD, PhD, Chair of Pathology and Laboratory Medicine and the Chief of Diagnostics at the Cleveland Clinic, served as co-chair for i3 Health's continuing medical education (CME)–/nursing continuing professional development (NCPD)–approved virtual tumor board: Multidisciplinary Management...
04.03.2024
Multiple Myeloma Awareness Month 2024: What Patients Need to Know
For Multiple Myeloma Awareness Month this March, Oncology Data Advisor hosted a live panel discussion geared towards patients living with multiple myeloma. Dr. Rahul Banerjee, Dr. Alankrita Taneja, Dr. Richa Thakur, and Dr. Gurbakhash Kaur helped put the myriad of...
04.02.2024
Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD
Last year, Jaffer Ajani, MD, Professor in the Department of Gastrointestinal (GI) Medical Oncology at MD Anderson Cancer Center, served as co-chair of i3 Health's Virtual Tumor Board, Building Comprehensive Care Plans in Esophagogastric Cancers, along with Lei Zhao, MD,...
03.27.2024
Introduction to Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Catherine Skefos, MA, MS, CGC
In this first episode of Oncology Data Advisor’s new podcast series, “Bridging the Gap in Cancer Care Through Genetic Counseling,” Hiam Abdel-Salam and Catherine Skefos provide an introduction to genetic counseling, including how they entered the field, what they do...
03.22.2024
Thirty Years in the Making: The Approval of Lifileucel for Metastatic Melanoma
Following the recent approval of lifileucel for unresectable or metastatic melanoma—the first cellular therapy to receive an approval for solid tumors—Matthew Hadfield, DO, member of the Oncology Data Advisor Fellows Forum and third-year Fellow at Brown University, sat down with...
03.22.2024
International Women’s Day With Alankrita Taneja, Maria Badillo, Ulka Vaishampayan, and Morana Vojnic
In celebration of Women's Day on March 8, Oncology Data Advisor hosted a live panel discussion in which the women of our Editorial Board and Fellows Forum share what the day means to them, progress that has been made in...
03.21.2024
Discovering Research Advances in Mesothelioma: Samuel Kareff, MD, MPH, and Estela Rodriguez, MD, MPH
In this Fellows Forum interview, Dr. Samuel Kareff speaks with Dr. Estela Rodriguez, Clinical Research Lead of the Thoracic Site Disease Group at the University of Miami Sylvester Comprehensive Cancer Center, about recent research advances in mesothelioma, the emerging roles...
03.18.2024
Rare Disease Day 2024 With Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree Seetharamu
On Rare Disease Day on February 29, members of the Oncology Data Advisor Editorial Board and Fellows Forum hosted a live panel discussion focused on the rare diseases that they treat, including tireless efforts underway to develop novel treatment strategies,...
03.14.2024
Exploring the Intersection of Emergency Medicine and Oncology With Joseph Oropeza and Joseph Kalis
In this interview, Joseph Kalis, PharmD, BCOP, introduces Joseph Oropeza, PharmD, BCCP, one of the newest Editorial Board members of Oncology Data Advisor. Dr. Oropeza shares what he does as an Emergency Medicine Pharmacist, the intersections of oncology and the...
03.12.2024
Colorectal Cancer Awareness Month With Allison Rosen, MS, and Matthew Hadfield, DO
In honor of Colorectal Cancer Awareness Month this March, Allison Rosen, MS, and Matthew Hadfield, DO, members of the OncData Editorial Board and Fellows Forum, sat down to discuss their perspectives on the month from both the clinical and survivorship...
03.06.2024
Expanding Clinical Trial Access With Decentralization and Technology: Waqas Haque and Shaalan Beg
In this installment of Oncology Data Advisor's Exploring AI in Oncology series, Dr. Waqas Haque speaks with Dr. Shaalan Beg, an Adjunct Associate Professor at the University of Texas (UT) Southwestern, who is spearheading efforts to decentralize clinical trials in...
03.01.2024
National Donor Day: How To Be the Match With Richa Thakur, MD, and Will Smith
On February 14, Oncology Data Advisor is celebrating National Donor Day and recognizing the contributions of individuals who have given organ and tissue donations for patients in need. In this interview, Fellows Forum member Dr. Richa Thakur has a conversation...
02.29.2024
Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward
In this interview, Dr. Jason Mouabbi, OncData Editorial Board Member and Breast Medical Oncologist at MD Anderson Cancer Center, speaks with Dr. Ross Maclean and Michael Glover about the debate surrounding accelerated FDA approvals, including their benefits, risks, and ways...
02.27.2024
National Cancer Prevention Month: Rising Trends and How to Combat Them
In honor of National Cancer Prevention Month 2024, members of the Oncology Data Advisor Editorial Board and Fellows Forum sat down for a panel discussion about the rising incidence of cancer diagnoses, factors contributing to them, and how to counsel...
02.26.2024
Breaking Developments in Neuroendocrine Tumor Research: Dr. Samuel Kareff and Dr. Aman Chauhan
In this Fellows Forum interview, Samuel Kareff, MD, MPH, interviews Aman Chauhan, MD, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester Comprehensive Cancer Center, about how he became involved in neuroendocrine cancer research, the latest developments...
02.23.2024
World Cancer Day 2024 with Oncology Data Advisor
In honor of World Cancer Day on February 4, members of the Oncology Data Advisor Fellows Forum and Editorial Board joined forces for a thought-provoking discussion about improving cancer care on a global scale, including treatment access, molecular testing, clinical...
02.23.2024
Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options
In honor of Gallbladder and Bile Duct Cancer Awareness Month this February, Fellows Forum members Dr. Waqas Haque and Dr. Matthew Hadfield sat down for a discussion on the challenges in diagnosis of gallbladder and bile duct cancers and the...
02.22.2024
National Cancer Prevention Month With Stephen Freedland and William Aronson
In honor of National Cancer Prevention Month, Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, sat down with Dr. William Aronson, Professor of Urology at the University of California, Los Angeles (UCLA) and...
02.08.2024
Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD
At the recent American Society of Hematology (ASH) Annual Meeting, numerous updates were presented with the potential to impact practice in relapsed/refractory multiple myeloma. While at the meeting, Urvi Shah, MD, Assistant Attending in the Myeloma Service at Memorial Sloan...
02.01.2024
Streamlining the Pathology Workflow Through AI: Waqas Haque and Leif Honda of TriMetis
This second episode of Oncology Data Advisor's podcast series, Exploring Artificial Intelligence in Oncology, features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based research, development, and testing. Dr....
01.26.2024
Coming Soon! Episode 2 Preview: "Streamlining Pathology Workflow Through Artificial Intelligence"
Coming Soon! Episode 2 of Oncology Data Advisor’s podcast series, "Exploring Artificial Intelligence in Oncology," features Leif Honda, Chief Innovation Officer at TriMetis, a digital pathology company focused on improving patient outcomes by accelerating human tissue-based research, development, and testing....
01.23.2024
Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer With Jason Mouabbi, MD, and Carlos Doti, MD
Recently, the FDA granted approval to capivasertib in combination with fulvestrant for patients with hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN alterations. In this interview, Editorial Board...
01.18.2024
Patterns of Care With BTK Inhibitors for CLL/SLL in the Community Setting: David Andorsky, MD
At the recent American Society of Hematology (ASH) Annual Meeting in San Diego, Dr. David Andorsky, MD, a Clinical Hematologist and Medical Oncologist at the Rocky Mountain Cancer Centers in Boulder, Colorado, presented his research and observations regarding patterns of...
01.09.2024
Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan
Recently, at the American Society of Hematology (ASH) Annual Meeting, Amer Zeidan, MBBS, MHS, the Interim Chief of Hematologic Malignancies Division at the Yale Cancer Center, presented his abstract regarding an investigation of oral decitabine and cedazuridine versus intravenous/subcutaneous hypomethylating...
01.09.2024
Epcoritamab for FL: Matt Hadfield, Alankrita Taneja, Tahi Ahmadi, Jacqueline Nielsen
Recently, Genmab and AbbVie announced updated results of the phase 1/2 EPCORE™ NHL-1 clinical trial of epcoritamab (epco) for patients with relapsed/refractory follicular lymphoma. In this interview, Dr. Matthew Hadfield and Dr. Alankrita Taneja of the Oncology Data Advisor Fellows...
01.08.2024
Managing Acute Leukemias and Lymphomas When Patients Stay Local: Dipti Patel-Donnelly, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Real-World Outcomes of Brexuctabtagene Autoleucel for B-Cell ALL: Evandro Bezerra, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Nurse Navigation to Address Socioeconomic Disparities in ALL Treatment: Greg Knight, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Exploring Revumenib for KMT2-Rearranged Acute Leukemias in the AUGMENT Trial: Ibrahim Aldoss, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Utilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Coping With Psychological Distress Prior to Hematopoietic Cell Transplantation: Richard Newcomb, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Investigating Odronextamab for R/R FL and DLBCL in the ELM-2 Study: Sabarish Ayyappan, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Exploring Acalabrutinib ± Obinutuzumab for CLL in the ELEVATE-TN Study: Jeff Sharman, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...
01.08.2024
Highlights of Multiple Myeloma Research Presented at ASH 2023: Urvi Shah, MD
At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this...

What's Oncology Data Advisor about?

Download our free app to listen on your phone

Oncology Data Advisor episodes:

Celebrating Head and Neck Cancer Awareness Month

Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability

Linvoseltamab for Relapsed/Refractory Multiple Myeloma: Updates on LINKER-MM1 From AACR 2024

Improving Breast Cancer Surgical Outcomes With Lymphovenous Bypass

AYA Cancer Awareness Week 2024

Additional Advances in HER2-Positive Metastatic Colorectal Cancer Research: Christopher Lieu, MD

National Doctor’s Day With Samuel Kareff, MD, MPH, and Matthew Hadfield, DO

Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes

Fighting Hereditary Colorectal Cancer With Genetic Counseling: Catherine Skefos and Julie Moskowitz

International Women’s Day: Perspectives in Medicine, Nursing, and Fellowship

Additional Advances in aTTP Research and Clinical Trials With Spero Cataland, MD

Kidney Cancer Awareness Month: Spotlight on Genetic Counseling

Additional Advances in Soft Tissue Sarcoma With Brian Rubin, MD, PhD

Multiple Myeloma Awareness Month 2024: What Patients Need to Know

Additional Advances in Esophagogastric Cancer Research and Clinical Trials With Jaffer Ajani, MD

Introduction to Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Catherine Skefos, MA, MS, CGC

Thirty Years in the Making: The Approval of Lifileucel for Metastatic Melanoma

International Women’s Day With Alankrita Taneja, Maria Badillo, Ulka Vaishampayan, and Morana Vojnic

Discovering Research Advances in Mesothelioma: Samuel Kareff, MD, MPH, and Estela Rodriguez, MD, MPH

Rare Disease Day 2024 With Rahul Banerjee, Matthew Hadfield, Joseph Kalis, and Nagashree Seetharamu

Exploring the Intersection of Emergency Medicine and Oncology With Joseph Oropeza and Joseph Kalis

Colorectal Cancer Awareness Month With Allison Rosen, MS, and Matthew Hadfield, DO

Expanding Clinical Trial Access With Decentralization and Technology: Waqas Haque and Shaalan Beg

National Donor Day: How To Be the Match With Richa Thakur, MD, and Will Smith

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward

National Cancer Prevention Month: Rising Trends and How to Combat Them

Breaking Developments in Neuroendocrine Tumor Research: Dr. Samuel Kareff and Dr. Aman Chauhan

World Cancer Day 2024 with Oncology Data Advisor

Gallbladder and Bile Duct Cancer Awareness Month: Improving Screening and Treatment Options

National Cancer Prevention Month With Stephen Freedland and William Aronson

Highlights of Multiple Myeloma Research Presented at ASH With Urvi Shah, MD

Streamlining the Pathology Workflow Through AI: Waqas Haque and Leif Honda of TriMetis

Coming Soon! Episode 2 Preview: "Streamlining Pathology Workflow Through Artificial Intelligence"

Capivasertib for PIK3CA/AKT1/PTEN–Altered Breast Cancer With Jason Mouabbi, MD, and Carlos Doti, MD

Patterns of Care With BTK Inhibitors for CLL/SLL in the Community Setting: David Andorsky, MD

Investigating Hypomethylating Agents for Myelodysplastic Syndromes With Amer Zeidan

Epcoritamab for FL: Matt Hadfield, Alankrita Taneja, Tahi Ahmadi, Jacqueline Nielsen

Managing Acute Leukemias and Lymphomas When Patients Stay Local: Dipti Patel-Donnelly, MD

Real-World Outcomes of Brexuctabtagene Autoleucel for B-Cell ALL: Evandro Bezerra, MD

Nurse Navigation to Address Socioeconomic Disparities in ALL Treatment: Greg Knight, MD

Exploring Revumenib for KMT2-Rearranged Acute Leukemias in the AUGMENT Trial: Ibrahim Aldoss, MD

Utilizing ctDNA to Assess Survival With Odronextamab for FL and DLBCL: Jon Arnason, MD

Investigating Talquetamab + Pomalidomide in the MonumenTAL-2 Study: Jeffrey Matous, MD

Improving QOL in Multiple Myeloma With Bortezomib Dose Reduction: Rahul Banerjee and Gurbakhash Kaur

Guiding Dietary Choices During Multiple Myeloma Treatment: Richa Parikh, MD

Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD

Coping With Psychological Distress Prior to Hematopoietic Cell Transplantation: Richard Newcomb, MD

Investigating Odronextamab for R/R FL and DLBCL in the ELM-2 Study: Sabarish Ayyappan, MD

Exploring Acalabrutinib ± Obinutuzumab for CLL in the ELEVATE-TN Study: Jeff Sharman, MD

Highlights of Multiple Myeloma Research Presented at ASH 2023: Urvi Shah, MD